Diabetic diarrhea

Current Gastroenterology Reports

Volumn 11, Issue 5, 2009, Pages 354-359

  Gould, Milena ^a   Sellin, Joseph H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; ANTIBIOTIC AGENT; BUDESONIDE; CARBONATE DEHYDRATASE II; CLONIDINE; EXENDIN 4; LACTOFERRIN; LOPERAMIDE; METFORMIN; MIGLITOL; PLACEBO; SORBITOL; TETRAHYDROLIPSTATIN;

ABDOMINAL CRAMP; ANORECTAL DISEASE; BLOATING; CARBOHYDRATE INTOLERANCE; CELIAC DISEASE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DIARRHEA; DISEASE ASSOCIATION; DISEASE DURATION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; ENTEROPATHY; ETHNIC GROUP; FECES INCONTINENCE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRANSIT; GENETIC ASSOCIATION; GENETIC RISK; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYDROGEN BREATH TEST; IDIOPATHIC DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; MICROSCOPIC COLITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS EXOCRINE INSUFFICIENCY; REVIEW; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SMALL INTESTINAL BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE; WEIGHT REDUCTION;

ALGORITHMS; ANTIDIARRHEALS; CELIAC DISEASE; CLONIDINE; COLITIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIARRHEA; DRUG THERAPY, COMBINATION; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; LOPERAMIDE; METFORMIN; OCTREOTIDE; PREVALENCE; RISK FACTORS; SWEETENING AGENTS; TEXAS; TREATMENT OUTCOME;

EID: 70349508760     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-009-0054-y     Document Type: Review

References (50)

1. Bytzer P, Talley NJ, Leemon M, et al.: Prevalence of gastrointestinal symptoms associated with diabetes mellitus. Arch Intern Med 2001, 161:1989-1996.
2. Vinik A, Erbas T: Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 2001, 68: 928-930, 932, 934-44.
3. Lysy J, Israeli E, Goldin E: The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol 1999, 94:2165-2170.
4. Berchtold P, Dahlqvist A, Gustafson, A, et al.: Effects of a biguanide (Metformin) on vitamin B12 and folic acid absorption and intestinal enzyme activities. Scand J Gastroenterol 1971, 6:751-754.
5. Bytzer P, Talley NJ, Jones MP, et al.: Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther 2001, 15:137-142.
6. Foss MT, Clement KD: Metformin as a cause of late-onset chronic diarrhea. Pharmacotherapy 2001, 21:1422-1424.
7. Ratnaike RN, Jones TE: Mechanisms of drug-induced diarrhoea in the elderly. Drugs Aging 1998, 13:245-253.
8. Byetta [package insert]. San Diego, CA: Amylin Pharmaceuticals; 2008. Available at http://pi.lilly.com/us/byetta-pi.pdf. Accessed April 2009.
9. Jacob S, Rabbia M, Meier MK, et al.: Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss. Diabetes Obes Metab 2009, 11:361-371.
10. Drent ML, vanAder Veen EA: Lipase inhibition: a novel concept in the treatment of obesity. Int J Obes Relat Metab Disord 1993, 17:241-244.
11. Acarya NV, Wilton LV, Rhakir SA: Safety profile of orlistat: results of a prescription-event monitoring study. Int J Obes (Lond) 2006, 30:1645-1652.
12. Sellin JH, Ghang EB: Therapy insight: gastrointestinal complications of diabetes-pathophysiology and management. Nat Clin Pract Gastroenterol Hepatol 2008, 5:162-171.
13. Kerlin P, Wong L: Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 1988, 95:982-988.
14. MacMahon M, Gibbons N, Mullins E, et al.: Are breath hydrogen tests valid in the elderly? Gerontology 1996, 42:40-45.
15. Bauer TM, Schwacha H, Steinbrückner B, et al.: Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J Hepatol 2000, 33:382-386.
16. Stotzer PO, Kilander AF: Comparison of the 1-gram (14)C-D-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth. Digestion 2000, 61:165-171.
17. Rhodes JM, Middleton P, Jewell DP: The lactulose hydrogen breath test as a diagnostic test for small bowel bacterial overgrowth. Scand J Gastroenterol 1979, 14:333-336.
18. Riordan SM, McIver CJ, Walker BM, et al.: The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996, 91:1795-1803.
19. Corazza GR, Menozzi MG, Strocchi A, et al.: The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990, 98:302-309.
20. Sellin JH, Hart R: Glucose malabsorption associated with rapid intestinal transit. Am J Gastroenterol 1992, 87:584-589.
21. Aktay AN, Lee PC, Kumar V, et al.: The prevalence and clinical characteristics of celiac disease in juvenile diabetes in Wisconsin. J Pediatr Gastroenterol Nutr 2001, 33:462-465.
22. Rensch MJ, Merenich JA, Lieberman M, et al.: Glutensensitive enteropathy in patients with insulin-dependent diabetes mellitus. Ann Intern Med 1996, 124:564-567.
23. Talal AH, Murray JA, Goeken JA, et al.: Celiac disease in an adult population with insulin dependent diabetes mellitus: Use of endomysial antibody testing. Am J Gastroenterol 1997, 92:1280-1284.
24. Fasano A, Berti I, Gerarduzzi T, et al.: Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: A large multicenter study. Arch Intern Med 2003, 163:286-292.
25. Dretzke J, Cummins C, Sandercock J, et al.: Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus. Health Technol Assess 2004, 8:iIi-xi, 1-183.
26. Larsson K, Carlsson A, Cederwall E, et al.: Annual screening detects celiac disease in children with type 1 diabetes. Pediatr Diabetes 2008, 9:354-359.
27. Salardi S, Volta U, Zucchini S, et al.: Prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid-1990s: An 18-year longitudinal study based on anti-endomysial antibodies. J Pediatr Gastroenterol Nutr 2008, 46:612-614.
28. Remes-Troche JM, Rios-Vaca A, Ramírez-Iglesias MT, et al.: High prevalence of celiac disease in Mexican Mestizo adults with type 1 diabetes. J Clin Gastroenterol 2008, 42:460-465.
29. Kaistha A, Castells S: Celiac disease in African American children with type 1 diabetes mellitus in inner city Brooklyn. Pediatr Endocrinol Rev 2008, 5(Suppl 4):994-998.
30. Smyth, DJ, Plagnot V, Walker NM, et al.: Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008, 359:2767-2777.
31. Plenge RM: Shared genetic risk factors for type 1 diabetes and celiac disease. N Engl J Med 2008, 359:2837-2838.
32. Bohr J, Tysk C,AEriksson S, et al.: Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996, 39:846-851.
33. Olesen M, EriksAon S, Bohr J, et al.: Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 2004, 53:536-541.
34. Pardi DS, Ramnath VR, Loftus EV Jr, et al.: Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol 2002, 97:2829-2833.
35. Koskela RM, Niemel SE, Karttunen TJ, et al.: Clinical characteristics of collagenous and lymphocytic colitis. Scand J Gastroenterol 2004, 39:837-845.
36. Warren BF, Edwards CM, Travis SP: 'Microscopic colitis' classification and terminology. Histopathology 2002, 40:374-376.
37. Corazza GR, Strocchi A, Rossi R, et al.: Sorbitol malabsorption in normal volunteers and in patients with coeliac disease. Gut 1988, 29:44-48.
38. Bauditz J, Norman K, Biering H, et al.: Severe weight loss caused by chewing gum. BMJ 2008, 336:96-97.
39. Nunes ACR, Pontes JM, Rosa A, et al.: Screening for pancreatic exocrine insufficiency in patients with diabetes mellitus Am J Gastroenterol 2003, 98:2672-2675.
40. Hardt PD, Hauenschild A, Nalop J, et al.: High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients. Pancreatology 2003, 3:395-402.
41. Hahn JU, Kerner W, Maisonneuve P, et al.: Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus. Pancreas 2008, 36:274-278.
42. Ewald N, Bretzel RG, Fantus IG, et al.: Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of prospective multi-centre trial. Diabetes Metab Res Rev 2007, 23:386-391.
43. Taniguchi T, Okazaki K, Okamoto M, et al.: High prevalence of autoantibodies against carbonic anhydrase II and lactoferrin in type 1 diabetes: Concept of autoimmune exocrinopathy and endocrinopathy of the pancreas. Pancreas 2003, 27:26-30.
44. Hardt PD, Ewald N, Bröckling K, et al.: Distinct autoantibodies against exocrine pancreatic antigens in European patients with type 1 diabetes mellitus and nonalcoholic chronic pancreatitis. JOP 2008, 9:683-689.
45. Schrader H, Menge BA, Schneider S et al.: Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis Gastroenterology 2009, 136:513-522.
46. Wald A, Tunuguntla AK: Anorectal sensorimotor dysfunction in fecal incontinence and diabetes mellitus. Modification with biofeedback therapy. N Engl J Med 1984, 310:1282-1287.
47. Russo A, Botten R, Kong MF, et al.: Effects of acute hyperglycaemia on anorectal motor and sensory function in diabetes mellitus. Diabet Med 2004, 21:176-182.
48. Fillmann HS, Llessuy S, Marroni CA, et al.: Diabetes mellitus and anal sphincter pressures: An experimental model in rats. Dis Colon Rectum 2007, 50:517-522.
49. Fedorak RN, Field M, Chang EB: Treatment of diabetic diarrhea with clonidine. Ann Intern Med 1985, 102:197-199.
50. Mourad FH, Gorard D, Thillainayagam AV et al.: Effective treatment of diabetic diarrhoea with somatostatin analogue, octreotide. Gut 1992, 33:1578-1580.